Rivernorth Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Rivernorth Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,410	Closed	-$2.75K	–	702
2023 Q1	$2.75K	Hold	34,410	–	–	﹤0.01%	576
2022 Q4	$5.51K	Hold	34,410	–	–	﹤0.01%	595
2022 Q3	$6K	Hold	34,410	–	–	﹤0.01%	736
2022 Q2	$6K	Hold	34,410	–	–	﹤0.01%	715
2022 Q1	$13K	Sell	34,410 -587	-2%	-$303	﹤0.01%	725
2021 Q4	$34K	Hold	34,997	–	–	﹤0.01%	593
2021 Q3	$31K	Buy	+34,997	New	+$45.5K	﹤0.01%	495

Rivernorth Capital Management's ORIAW Position: Q2 2023 in Review

Rivernorth Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 34,410 shares — an estimated $2.75K sold.

Rivernorth Capital Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $34K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Rivernorth Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Rivernorth Capital Management sold 34,410 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $2.75K.
Rivernorth Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
Rivernorth Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $34K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Rivernorth Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.